Cargando…
Advances in the management of atrial fibrillation in congestive heart failure
Atrial fibrillation, a common problem in patients with heart failure, is associated with increased mortality and morbidity. Pharmacological as well as invasive management and the endpoints of such management are complex. Recent randomized trials indicate that a rate-control strategy, along with anti...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medicine Reports Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920707/ https://www.ncbi.nlm.nih.gov/pubmed/20948741 http://dx.doi.org/10.3410/M1-4 |
_version_ | 1782185305103663104 |
---|---|
author | Gopinathannair, Rakesh Olshansky, Brian |
author_facet | Gopinathannair, Rakesh Olshansky, Brian |
author_sort | Gopinathannair, Rakesh |
collection | PubMed |
description | Atrial fibrillation, a common problem in patients with heart failure, is associated with increased mortality and morbidity. Pharmacological as well as invasive management and the endpoints of such management are complex. Recent randomized trials indicate that a rate-control strategy, along with anticoagulation treatment with warfarin, when appropriate, has a similar outcome in terms of mortality and morbidity as rhythm control, and could, therefore, be considered as the primary management strategy for atrial fibrillation in patients with heart failure. |
format | Text |
id | pubmed-2920707 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Medicine Reports Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-29207072010-10-14 Advances in the management of atrial fibrillation in congestive heart failure Gopinathannair, Rakesh Olshansky, Brian F1000 Med Rep Review Article Atrial fibrillation, a common problem in patients with heart failure, is associated with increased mortality and morbidity. Pharmacological as well as invasive management and the endpoints of such management are complex. Recent randomized trials indicate that a rate-control strategy, along with anticoagulation treatment with warfarin, when appropriate, has a similar outcome in terms of mortality and morbidity as rhythm control, and could, therefore, be considered as the primary management strategy for atrial fibrillation in patients with heart failure. Medicine Reports Ltd 2009-01-21 /pmc/articles/PMC2920707/ /pubmed/20948741 http://dx.doi.org/10.3410/M1-4 Text en © 2009 Medicine Reports Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes |
spellingShingle | Review Article Gopinathannair, Rakesh Olshansky, Brian Advances in the management of atrial fibrillation in congestive heart failure |
title | Advances in the management of atrial fibrillation in congestive heart failure |
title_full | Advances in the management of atrial fibrillation in congestive heart failure |
title_fullStr | Advances in the management of atrial fibrillation in congestive heart failure |
title_full_unstemmed | Advances in the management of atrial fibrillation in congestive heart failure |
title_short | Advances in the management of atrial fibrillation in congestive heart failure |
title_sort | advances in the management of atrial fibrillation in congestive heart failure |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920707/ https://www.ncbi.nlm.nih.gov/pubmed/20948741 http://dx.doi.org/10.3410/M1-4 |
work_keys_str_mv | AT gopinathannairrakesh advancesinthemanagementofatrialfibrillationincongestiveheartfailure AT olshanskybrian advancesinthemanagementofatrialfibrillationincongestiveheartfailure |